ALX Oncology to Present New Evorpacept Clinical Data in Myelodysplastic Syndromes at 63rd ASH Annual Meeting

NEXT STORY
Vincerx Pharma Announces Presentations at the American Society of Hematology Annual Meeting
PREV STORY
RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO 
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Industrial Microbiology Market To Be Worth USD 17.71 Billion by 2027| Emergen Research

author_avatar
NASDAQ Market News

Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT

MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc, formerly Skyline Medical Inc, ...

author_avatar
NASDAQ Market News

Leda Health Wins CES 2022 Innovation Award for Early Evidence Kit and Platform

author_avatar
NASDAQ Market News